United States · FDA National Drug Code directory
POLYMYXIN B
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-321_b473292e-e7ce-4ce2-aec7-91604b82bb11
- Product NDC
- 63323-321
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- POLYMYXIN B SULFATE
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091117
- Source listing expiry
- 20261231
Source-listed ingredients
- POLYMYXIN B SULFATE — 500000 [USP'U]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 TRAY (63323-321-12) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63323-321-02) · 63323-321-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →